Innovative data solutions

In the last few years, the pharmaceutical industry has seen a huge increase in late phase, or post-marketing studies, intended to establish long-term safety and efficacy profiles for pharmaceutical drugs

The study types expected to see the greatest levels of growth are health economics outcomes research (HEOR), post approval safety studies (PASS) and Phase IV studies.

Cisiv has over 15 years of experience developing and implementing the best in class solutions specifically for late phase research. Our baseline plus suite of web based tools provides a simple and intuitive platform giving the highest quality data for your study.